Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy
Protein & Cell · 01.11.2024 · 15 (11) · 796-817
DOI: 10.1093/procel/pwae032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, online erschienen am 23.05.2024. Verfasst von Junpeng Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Pioneering Innovation Center, School of Life Sciences, Peking University, Beijing 100871, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, DNA Methylation, Transcriptome, Chromatin. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and is characterized by primary left ventricular hypertrophy usually caused by mutations in sarcomere genes. The mechanism underlying cardiac remodeling in HCM remains incompletely understood. An investigation of HCM through integrative analysis at multi-omics levels will be helpful for treating HCM. DNA methylation and chromatin accessibility, as well as gene expression, were assessed by nucleosome occupancy and methylome sequencing (NOMe-seq) and RNA-seq, respectively, using the cardiac tissues of HCM patients. Compared with those of the controls, the transcriptome, DNA methylome, and chromatin accessibility of the HCM myocardium showed multifaceted differences. At the transcriptome level, HCM hearts returned to the fetal gene program through decreased sarcomeric and metabolic gene expression and increased extracellular matrix gene expression. In the DNA methylome, hypermethylated and hypomethylated differentially methylated regions were identified in HCM. At the chromatin accessibility level, HCM hearts showed changes in different genome elements. Several transcription factors, including SP1 and EGR1, exhibited a fetal-like pattern of binding motifs in nucleosome-depleted regions in HCM. In particular, the inhibition of SP1 or EGR1 in an HCM mouse model harboring sarcomere mutations markedly alleviated the HCM phenotype of the mutant mice and reversed fetal gene reprogramming. Overall, this study not only provides a high-precision multi-omics map of HCM heart tissue but also sheds light on the therapeutic strategy by intervening in the fetal gene reprogramming in HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Pioneering Innovation Center, School of Life Sciences, Peking University, Beijing 100871, China.
- Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
- Beijing Advanced Innovation Center for Genomics (ICG), Ministry of Education Key Laboratory of Cell Proliferation and Differentiation, Beijing 100871, China.
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100037, China.
- Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
- Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
ORCID-Profile: Junpeng Gao, Mengya Liu, Minjie Lu, Yuxuan Zheng, Yan Wang, Jingwei Yang, Xiaohui Xue, Yun Liu, Fuchou Tang, Shuiyun Wang, Lei Song, Lu Wen, Jizheng Wang
Förderung
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- China Postdoctoral Science Foundation
Zitieren
APA
Gao, J., Liu, M., Lu, M., Zheng, Y., Wang, Y., Yang, J., Xue, X., Liu, Y., Tang, F., Wang, S., Song, L., Wen, L., & Wang, J. (2024). Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy. Protein & Cell, 15(11), 796-817. https://doi.org/10.1093/procel/pwae032
Vancouver
Gao J, Liu M, Lu M, Zheng Y, Wang Y, Yang J, et al. Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy. Protein & Cell. 2024;15(11):796-817. doi:10.1093/procel/pwae032
BibTeX
@article{Gao2024,
author = {Gao, Junpeng and Liu, Mengya and Lu, Minjie and Zheng, Yuxuan and Wang, Yan and Yang, Jingwei and Xue, Xiaohui and Liu, Yun and Tang, Fuchou and Wang, Shuiyun and Song, Lei and Wen, Lu and Wang, Jizheng},
title = {Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy},
journal = {Protein & Cell},
year = {2024},
volume = {15},
number = {11},
pages = {796--817},
doi = {10.1093/procel/pwae032}
}
EUVIMED